HHS Seeks Input On Defining Drug "Rebates," "Discounts," And "Price Concessions" For HCR Rule
This article was originally published in The Pink Sheet Daily
Executive Summary
HHS proposed rule on state health plan exchanges implements health reform requirement for qualified health plans to submit data on amounts and types of rebates, discounts and concessions PBMs negotiate and pass on to the plan sponsor.
You may also be interested in...
Drug Coverage In Exchange Plans Should Be On Par With Other "Essential Benefits," PhRMA Tells IoM
PhRMA was among a number of stakeholders presenting comments Jan. 14 to the committee on criteria and methods for determining and updating what qualifies as "essential health benefits" in the exchange plans.
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.
One Trial Plus Supportive Evidence Is Enough For Hospital-, Ventilator-Acquired Pneumonia Indication, Panel Says
Anti-Infective Drugs Advisory Committee members viewed one-trial as practical means of gaining efficacy data.